Wild type ApoA-II gene does not rescue senescence-accelerated mouse (SAMP1) from short life span and accelerated mortality

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 9, 2000, Pages

  Wang, J ^a   Matsushita, T ^a   Kogishi, K ^a   Xia, C ^a   Ohta, A ^a   Chiba, T ^a   Nakamura, A ^a   Kondo, H ^a   Mori, M ^a   Hosokawa, M ^a   Higuchi, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; LIPOPROTEIN;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; LIFESPAN; LIPOPROTEIN METABOLISM; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENESCENCE;

EID: 0034545881     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.9.B432     Document Type: Article

References (43)

1. A new murine model of accelerated senescence
2. Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence
3. Senescence-Accelerated Mouse (SAM): With special reference to development and pathological phenotypes
4. Genetic characterization of Senescence-Accelerated Mouse (SAM)
5. Molecular genetic characterization of Senescence-Accelerated Mouse (SAM)
6. Genetic typing of the Senescence-Accelerated Mouse (SAM) strains with microsatellite markers
7. Systemic senile amyloid in senescence accelerated mice: A unique fibril protein demonstrated in tissue from various organs by the unlabeled immunoperoxidase method
8. Amyloid deposits and amyloidosis. The β-fibrilloses Part I
9. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
10. Advances in amyloidosis
11. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation
12. The pathogenesis of amyloidosis: Understanding general principles
13. Proteins of the systemic amyloidosis
14. Prion diseases and the BSE crisis
15. Domain stability in immunoglobulin light chain deposition disorders
16. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
17. SAM is an apoA-II apolipoprotein of mouse high density lipoproteins
18. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice: Relationship between the molecular type of apoA-II and mouse senile amyloidosis
19. SAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis
20. Genetic analysis of murine senile amyloidosis
21. Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II
22. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
23. Amyloid fibril toxicity in Alzheimer's disease and diabetes
24. c reduces the plasma level and size of high density lipoprotein
25. Accelerated senile amyloidosis induced by amyloidogenic apoA-II gene shortens the life span of mice but does not accelerate the rate of senescence
26. Regulation of the metabolism of plasma lipoproteins by apolipoprotein A-II
27. Spontaneous age-associated amyloidosis in Senescence-Accelerated Mouse (SAM)
28. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice
29. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies
30. Grading score system: A method for evaluation of the degree of senescence in senescence accelerated mouse (SAM)
31. Grading score system: A method of evaluation of the degree of senescence in Senescence-accelerated Mouse (SAM)
32. Nonparametric estimation from incomplete observation
33. The asymptotic properties of comparative test for comparing survival distributions
34. Serum amyloid P component enhances induction of murine amyloidosis
35. Genetic markers for studies of atherosclerosis and related risk factors
36. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition
37. Genetic control of lipid transport in mice: II. Genes controlling structure of high density lipoproteins
38. Overexpression of apolipoprotein A-II in transgenic mice converts high density lipoproteins to proinflammatory particles
39. Metabolism of senile amyloid precursor and amyloidogenesis: Age-related acceleration of apolipoprotein A-II clearance in the senescence accelerated mouse
40. Age-associated decrease in the mRNA levels and the rate of synthesis of apoA-II in murine senile amyloidosis
41. Mouse senile amyloid deposition is suppressed by adenovirus-mediated overexpression of amyloid-resistant apolipoprotein A-II